|
Volumn 14, Issue 2, 2000, Pages 207-208
|
Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
DIDANOSINE;
HYDROXYUREA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
VIREMIA;
ANTI-HIV AGENTS;
DIDANOSINE;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HIV INFECTIONS;
HUMANS;
HYDROXYUREA;
PALLIATIVE CARE;
VIREMIA;
|
EID: 0034001851
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200001280-00020 Document Type: Letter |
Times cited : (6)
|
References (4)
|